文献速递肝胆胰外科围术期管理与 ERAS

鞘内吗啡对胰十二指肠切除术后阿片类药物用量及功能恢复的影响

Intrathecal Morphine and Effect on Opioid Consumption and Functional Recovery after Pancreaticoduodenectomy.
PubMed 文献 · J Am Coll Surg · 2022-05-04

该回顾性研究纳入2014至2020年233例胰十二指肠切除术患者,比较无脊髓镇痛、单次鞘内吗啡(ITM)及ITM联合腹横肌平面阻滞(ITM+TAP)的效果。结果显示ITM与ITM+TAP组术后早期及总住院阿片类药物用量更低,功能恢复时间和住院时间缩短,且阿片相关并发症无差异。

要点

  • ITM可降低胰十二指肠切除术后阿片类药物用量。
  • ITM与功能恢复时间和住院时间缩短相关。
  • ITM不增加阿片相关并发症,安全有效。

核心结论

  • ITM与胰十二指肠切除术后早期及总住院阿片用量减少、功能恢复时间及住院时间缩短相关,且安全有效。

研究设计与样本

  • 回顾性研究,纳入2014至2020年接受胰十二指肠切除术的患者233例,中位年龄67岁。
  • 患者分为无脊髓镇痛组(36.5%)、ITM组(49.3%)和ITM+TAP组(14.2%)。

主要发现

  • 术后第0至3天平均疼痛评分三组相似:无脊髓镇痛组2.8,ITM组2.6,ITM+TAP组2.3。
  • 术后第0至3天总吗啡当量消耗量:ITM组121 mg,ITM+TAP组132 mg,均低于无脊髓镇痛组的232 mg(p < 0.0001)。
  • 术后第4天至出院平均每日吗啡当量消耗量:ITM组18 mg,ITM+TAP组13.1 mg,均低于无脊髓镇痛组的32.9 mg(p = 0.0016)。
  • ITM和ITM+TAP组的功能恢复时间及住院时间较无脊髓镇痛组显著缩短,多因素分析结果一致。
  • 三组阿片相关并发症发生率无差异。

临床怎么用

  • 胰十二指肠切除术围术期可考虑使用ITM作为安全有效的镇痛方式,以减少阿片用量并促进恢复。

局限性

  • 回顾性研究设计,可能存在选择偏倚和混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Single-shot intrathecal morphine (ITM) is an effective strategy for postoperative analgesia, but there are limited data on its safety, efficacy, and relationship with functional recovery among patients undergoing pancreaticoduodenectomy. STUDY DESIGN: This was a retrospective review of patients undergoing pancreaticoduodenectomy from 2014 to 2020 as identified by the institutional NSQIP Hepato-pancreato-biliary database. Patients were categorized by having received no spinal analgesia, ITM, or ITM with transversus abdominus plane block (ITM+TAP). The primary outcomes were average daily pain scores from postoperative days (POD) 0 to 3, total morphine equivalents (MEQ) consumed over POD 0 to 3, and average daily inpatient MEQ from POD 4 to discharge. Secondary outcomes included the incidence of opioid related complications, length of stay, and functional recovery. RESULTS: A total of 233 patients with a median age of 67 years were included. Of these, 36.5% received no spinal analgesia, 49.3% received ITM, and 14.2% received ITM+TAP. Average pain scores in POD 0 to 3 were similar by mode of spinal analgesia (none [2.8], ITM [2.6], ITM+TAP [2.3]). Total MEQ consumed from POD 0 to 3 were lower for patients who received ITM (121 mg) and ITM+TAP (132 mg), compared with no spinal analgesia (232 mg) (p < 0.0001). Average daily MEQ consumption from POD 4 to discharge was lower for ITM (18 mg) and ITM+TAP (13.1 mg) cohorts compared with no spinal analgesia (32.9 mg) (p = 0.0016). Days to functional recovery and length of stay were significantly reduced for ITM and ITM+TAP compared with no spinal analgesia. These findings remained consistent through multivariate analysis, and there were no differences in opioid-related complications among cohorts. CONCLUSIONS: ITM was associated with reduced early postoperative and total inpatient opioid utilization, days to functional recovery, and length of stay among patients undergoing pancreaticoduodenectomy. ITM is a safe and effective form of perioperative analgesia that may benefit patients undergoing pancreaticoduodenectomy.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Burchard PR, Melucci AD, Lynch O, et al. Intrathecal Morphine and Effect on Opioid Consumption and Functional Recovery after Pancreaticoduodenectomy. J Am Coll Surg. 2022. PMID: 35758927. doi:10.1097/XCS.0000000000000261

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。